HIV/AIDS Therapy
Inhibition of CTL function by immunosuppressive therapy may enhance HIV-1 replication
Published in AIDS Weekly, January 9th, 2006
According to a report from Germany, "Studies in HIV-1 infected long-term non-progressors could demonstrate a strong HIV-1-specific CTL response, but it is difficult to prove that this strong CTL response actually is the cause of the efficient control of HIV-1 and not the consequence of low HIV-1 replication in these patients.
"Studies of HIV-1-specific immunity and viral replication in patients undergoing immunosuppressive therapy provide important opportunities to understand the role of HIV-1-specific T-cells."
"In [our]...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-01-09)
More Articles from AIDS Weekly
- HIV/AIDS Drug Resistance
Genetic variants may predict virologic failure and/or emergence of drug-resistant HIV - HIV/AIDS Pathogenesis
HIV virions without the nucleocapsid still contain significant amounts of RNA - HIV/AIDS Screening
Prevalence of primary HIV infection estimated among symptomatic ambulatory patients - HIV/AIDS Seroconversion
HIV-1 variation determined within several weeks of estimated transmission - Diagnostics
HIV-associated cardiomyopathy can be detected early and may be effectively treated - Disease Control
High morbidity continues to be associated with diarrheal diseases - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
